Study_No,Study_ID,Arm_ID,Year,Drug,No_randomised,WeightContM,WeightContSD,WeightContN,WeightContChangeEndpoint,WeightGainSDOrigin,ProlactinM,ProlactinSD,ProlactinN,ProlactinChangeEndpoint,ProlactinSDOrigin,QTcM,QTcSD,QTcN,QTcChangeEndpoint,QTcSDOrigin,FullStudyName,corr_auth,corr_auth_email,other_email,answer_after_1_mail,bibkey
3687,ENLIGHTEN-1,76023,2018,Olanzapine,133,,,,,,,,,,,,,,,,"McDonnell D, Potkin SG, Simmons A, Jiang Y, DiPetrillo L, Silverman B. A phase 3 study to determine the antipsychotic efficacy and safety of alks 3831 in adult patients with acute exacerbation of schizophrenia. Schizophrenia Bulletin2018",Professor Potkin,sgpotkin@uci.edu,,,McDonnell2018
3687,ENLIGHTEN-1,76159,2018,Placebo,134,,,,,,,,,,,,,,,,,,,,,McDonnell2018
3325,NCT01810380a,8876,2016,Brexpiprazole,150,,,,,,,,,,,,,,,,"Marder SR, Hakala MJ, Josiassen MK et al.Brexpiprazole in patients with schizophrenia: Overview of short-and long-term phase 3 controlled studies. Acta Neuropsychiatr2016",Dr Marder,marder@ucla.edu,,,Marder2017
3325,NCT01810380a,9117,2016,Placebo,163,,,,,,,,,,,,,,,,,,,,,Marder2017
3325,NCT01810380b,9019,2016,Quetiapine,154,,,,,,,,,,,,,,,,,,,,,Marder2017
3325,NCT01810380b,9117,2016,Placebo,163,,,,,,,,,,,,,,,,,,,,,Marder2017
968,Study RGH-MD-05,3170,2015,Cariprazine,151,,,,,,,,,,,,,,,,"Kane JM, Zukin S, Wang Y et al.Efficacy and safety of cariprazine in acute exacerbation of schizophrenia: Results from an international, phase iii clinical trial. Journal of clinical Psychopharmacology2015",Dr Kane,JKane2@NSHS.edu,,,Kane2015b
968,Study RGH-MD-05,5117,2015,Placebo,147,,,,,,,,,,,,,,,,,,,,,Kane2015b
59,Bugarski-Kirola,134,2014,Placebo,79,0.6,5,80,change,sd estimated from mean of SDs,,,,,,,,,,,"Bugarski-Kirola D, Wang A, Abi-Saab D, Blattler T. A phase ii/iii trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia -results from the candlelyte study. European Neuropsychopharmacology2014",Dr Burgarksi-Kirola,dragana.bugarski-kirola@roche.com,"kontakt falsch, Roche kontaktiert","keine Mitarbeiter mehr bei Roche, um neuen Kontakt gebeten",Bugarski2014
59,Bugarski-Kirola,133,2014,Olanzapine,63,2.6,5,62,change,sd estimated from mean of SDs,,,,,,,,,,,,,,,,Bugarski2014
394,Schmidt 2014,837,2014,Placebo,101,,,,,,-6.68,36.7063236773344,99,change,sd estimated from mean of SDs,,,,,,"Schmidt ME, Kent JM, Daly E et al.A double-blind, randomized, placebo-controlled study with jnj-37822681, a novel, highly selective, fast dissociating d2 receptor antagonist in the treatment of acute exacerbation of schizophrenia. European Neuropsychopharmacology2012",Dr Schmidt,mschmid4@its.jnj.com,,komische Antwort,Schmidt2014
998,Cantillon 2014,3254,2014,Aripiprazole,20,,,,,,,,,,,,,,,,Cantillon M. Efficacy and safety of novel dopamine serotonin stabilizer rp 5063 in acute schizophrenia and schizoaffective disorder. Schizophrenia Research2014,Dr Cantillon,mcantillon@revivapharma.com,,,Cantillon2015
998,Cantillon 2014,3255,2014,Placebo,39,,,,,,,,,,,,,,,,,,,,,Cantillon2015
1010,Downing 2014,3278,2014,Placebo,295,,,,,,,,,,,,,,,,"Downing AM, Kinon BJ, Millen BA et al.A double-blind, placebo-controlled comparator study of ly2140023 monohydrate in patients with schizophrenia. BMC Psychiatry2014",Dr Downing,downing_anncatherine_m@lilly.com,,Daten erhalten,Downing2014
1010,Downing 2014,3279,2014,Risperidone,143,,,,,,50.9,36.7063236773344,142,change,sd estimated from mean of SDs,,,,,,,,,,,Downing2014
3171,NCT00563706,7916,2014,Risperidone,43,,,,,,,,,,,,,,,,,,,keine Kontakte auffindbar,,NCT005637062007
3171,NCT00563706,8318,2014,Placebo,37,,,,,,,,,,,,,,,,,,,,,NCT005637062007
140,Egan 2013,276,2013,Olanzapine,47,,,,,,,,,,,,,,,,"Egan MF, Zhao X, Smith A et al.Randomized controlled study of the t-type calcium channel antagonist mk-8998 for the treatment of acute psychosis in patients with schizophrenia. Human Psychopharmacology2013",Dr Egan,michael.egan@merck.com,,,Egan2013
140,Egan 2013,277,2013,Placebo,83,,,,,,,,,,,,,,,,,,,,,Egan2013
3114,DeMartinis 2012,7859,2013,Risperidone,37,,,,,,,,,,,,,,,,DeMartinis NA. Results of a phase 2A proof-of-concept trial with a pde10a inhibitor in the treatment of acute exacerbation of schizophrenia. Biological Psychiatry2012,,,keine Kontakte auffindbar,,DeMartinis2012
3114,DeMartinis 2012,8261,2013,Placebo,74,,,,,,,,,,,,,,,,,,,,,DeMartinis2012
348,Pfizer 2008,737,2008,Placebo,,,,,,,,,,,,,,,,,"Pfizer. Dose-response study to evaluate safety, efficacy, and pharmacokinetics of pf-00217830 compared with placebo in acute exacerbation of schizophrenia. 2007",,,keine Kontakte auffindbar,,Pfizer2007
348,Pfizer 2008,736,2008,Aripiprazole,,,,,,,,,,,,,,,,,,,,,,Pfizer2007
28,Barbato 2007d,63,2007,Haloperidol,52,,,,,,,,,,,,,,,,,,,keine Kontakte auffindbar,,Barbato2007
28,Barbato 2007d,3154,2007,Placebo,51,,,,,,,,,,,,,,,,,,,,,Barbato2007
219,Janssen CR012625a,449,2007,Placebo,138,-1.59,3.61969389008628,138,change,sd estimated from mean of SDs,8.57,43.7222497000445,138,endpoint,sd estimated from mean of SDs,,,,,,,,,,,Hirayasu2010
219,Janssen CR012625a,448,2007,Paliperidone,136,0.4,3.61969389008628,134,change,sd estimated from mean of SDs,69.02,43.7222497000445,134,endpoint,sd estimated from mean of SDs,,,,,,"Hirayasu Y, Tomioka M, Iizumi M, Kikuchi H. A double-blind, placebo-controlled, comparative study of paliperidone extended release (er) tablets in patients with schizophrenia. JpnJClinPsychopharmacol2010",Dr Marder,marder@ucla.edu,,,Hirayasu2010
219,Janssen CR012625b,449,2007,Placebo,138,-1.59,3.61969389008628,138,change,sd estimated from mean of SDs,8.57,43.7222497000445,138,endpoint,sd estimated from mean of SDs,,,,,,,,,,,Hirayasu2010
219,Janssen CR012625b,447,2007,Olanzapine,47,1.36,3.61969389008628,46,change,sd estimated from mean of SDs,26.53,43.7222497000445,46,endpoint,sd estimated from mean of SDs,,,,,,,,,,,Hirayasu2010
521,Ahmed 2007,2201,2007,Placebo,150,-1,5,143,change,sd estimated from mean of SDs,,,,,,,,,,,"Ahmed S, Casey D. E., Yeung P. P., Barbato L. M., Heisterberg J., ShapiraN. A. Lipid profile among patients with schizophrenia randomized to bifeprunox, placebo, or olanzapine: A comparison of results: 11th international congress on schizophrenia research; 2007 mar 28-apr 1, colorado springs, colorado, usa. 2007",,,keine Kontakte auffindbar,,Ahmed2007
521,Ahmed 2007,2200,2007,Olanzapine,150,2,5,141,change,sd estimated from mean of SDs,,,,,,,,,,,,,,,,Ahmed2007
539,Barbato 2007c,2243,2007,Olanzapine,150,,,,,,,,,,,,,,,,"19 Barbato LMNJWHJYPPSNA. Efficacy and metabolic profile of bifeprunox in patients with schizophrenia: 11th international congress on schizophrenia research; 2007 mar 28-apr 1, colorado springs, colorado, usa. 2007",,,keine Kontakte auffindbar,,Barbato2007
539,Barbato 2007c,2244,2007,Placebo,145,,,,,,,,,,,,,,,,,,,,,Barbato2007
632,Cutler 2006,2297,2006,Placebo,88,,,,,,,,,,,,,,,,"Cutler AJ, Marcus RN, Hardy SA, O’Donnell A, Carson WH, McQuade RD. The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia. Spectrums2006; 11",Dr Cutler,acutler@coreresearch.com,flascher Contact neue Mail über Firma,,Cutler2006
632,Cutler 2006,2296,2006,Aripiprazole,94,,,,,,,,,,,,,,,,,,,,,Cutler2006
118,Corrigan 2004,230,2004,Placebo,87,,,,,,,,,,,,,,,,"Corrigan MH, Gallen CC, Bonura ML, Merchant KM, Sonepiprazole Study G. Effectiveness of the selective d4 antagonist sonepiprazole in schizophrenia: A placebo-controlled trial. Biological Psychiatry2004",Dr Corrigan,medinfo@correvio.com,,"Autor hat keine Daten, mail an Pfizer geschickt",Corrigan2004
118,Corrigan 2004,229,2004,Olanzapine,93,,,,,,,,,,,,,,,,,,,,,Corrigan2004
312,Meltzer 2004,660,2004,Placebo,98,-0.6,3.61969389008628,96,change,sd estimated from mean of SDs,,,,,,,,,,,"253 Meltzer HY, Arvanitis L, Bauer D, Rein W, Meta-Trial Study G. Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. American Journal of Psychiatry2004; 161: 975–84",Dr Meltzer,herbert.meltzer@vanderbilt.edu,falscher Kontakt; neuer Kontakt: medcommunications@northwestern.edu,,Meltzer2004
312,Meltzer 2004,659,2004,Haloperidol,98,0.5,3.61969389008628,95,change,sd estimated from mean of SDs,,,,,,,,,,,,,,,,Meltzer2004
231,Kane 2002a,472,2002,Aripiprazole,204,0.65,3.61969389008628,204,change,sd estimated from mean of SDs,-7.05,36.7063236773344,179,change,sd estimated from mean of SDs,-2.7,24.757979667836,204,change,sd estimated from mean of SDs,"Kane JM, Carson WH, Saha AR et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. Journal of clinical Psychiatry 2002",Dr Kane,JKane2@NSHS.edu,,,Kane2002
231,Kane 2002a,474,2002,Placebo,106,0.2,3.61969389008628,104,change,sd estimated from mean of SDs,-1.8,36.7063236773344,96,change,sd estimated from mean of SDs,-3.45,24.757979667836,106,change,sd estimated from mean of SDs,,,,,,Kane2002
231,Kane 2002b,474,2002,Placebo,106,0.2,3.61969389008628,104,change,sd estimated from mean of SDs,-1.8,36.7063236773344,96,change,sd estimated from mean of SDs,-3.45,24.757979667836,106,change,sd estimated from mean of SDs,,,,,,Kane2002
901,Study 93202 2002a,3020,2002,Aripiprazole,34,,,,,,,,,,,,,,,,2002 S9. Center for drug evaluation and research. Application number 21-436. Medical review(s). http://wwwfdagov 2002,,,keine Kontakte auffindbar,,Study932022002
901,Study 93202 2002a,3022,2002,Placebo,35,,,,,,,,,,,,,,,,,,,,,Study932022002
901,Study 93202 2002b,3021,2002,Haloperidol,34,,,,,,,,,,,,,,,,,,,,,Study932022002
901,Study 93202 2002b,3022,2002,Placebo,35,,,,,,,,,,,,,,,,,,,,,Study932022002
115,Cooper 2000a,223,2000,Placebo,53,-1.4,3.61969389008628,53,change,sd estimated from mean of SDs,,,,,,,,,,,"Cooper SJ, Tweed J, Raniwalla J, Butler A, Welch C. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatrica Scandinavica 2000",Professor Cooper,sjcooperqub@gmail.com,,,Cooper2000
115,Cooper 2000a,222,2000,Chlorpromazine,53,1.4,3.61969389008628,53,change,sd estimated from mean of SDs,,,,,,,,,,,,,,,,Cooper2000
115,Cooper 2000b,223,2000,Placebo,53,-1.4,3.61969389008628,53,change,sd estimated from mean of SDs,,,,,,,,,,,"Cooper SJ, Tweed J, Raniwalla J, Butler A, Welch C. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatrica Scandinavica 2000",Professor Cooper,sjcooperqub@gmail.com,,,Cooper2000
115,Cooper 2000b,224,2000,Zotepine,53,2.4,3.61969389008628,53,change,sd estimated from mean of SDs,,,,,,,,,,,,,,,,Cooper2000
367,Ramu 1999,778,1999,Chlorpromazine,27,,,,,,,,,,,,,,,,"Ramu MG, Chaturvedi DD, Venkataram BS et al. A double blind controlled study on the role of bahmyadiyoga and tagara in navonmada (acute schizophrenia). In: Ayurvedic management of unmada (schizophrenia). 1999",,,keine Kontakte auffindbar,,Ramu1999a
367,Ramu 1999,779,1999,Placebo,27,,,,,,,,,,,,,,,,,,,,,Ramu1999a
855,Ramu 1999a,2887,1999,Chlorpromazine,22,,,,,,,,,,,,,,,,,,,,,Ramu1999b
855,Ramu 1999a,2888,1999,Placebo,20,,,,,,,,,,,,,,,,,,,,,Ramu1999b
740,Keck 1998,2630,1998,Ziprasidone,47,0,3.61969389008628,47,change,sd estimated from mean of SDs,,,,,,414.8,31.3,42,endpoint,sd estimated from mean of SDs,"Keck, P., Jr., Buffenstein A, Ferguson J et al. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 4-week placebo-controlled trial. Psychopharmacology 1998; 140: 173–84.",Dr Keck,paul.keck@uc.edu,,,Keck1998
740,Keck 1998,2629,1998,Placebo,48,0,3.61969389008628,48,change,sd estimated from mean of SDs,,,,,,401.1,24.5,41,endpoint,sd estimated from mean of SDs,,,,,,Keck1998
718,Jann 1997,2582,1997,Placebo,18,,,,,,,,,,,,,,,,"Jann MW, Crabtree BL, Pitts WM, Lam YW, Carter JG. Plasma alpha-one acid glycoprotein and haloperidol concentrations in schizophrenic patients. Neuropsychobiology 1997; 36: 32–6.",Dr Jann,jann_mw@mercer.edu,falscher Kontakt: neuer Kontakt: alexander.branch@unthsc.edu,,Jann1997
718,Jann 1997,2581,1997,Haloperidol,18,,,,,,,,,,,,,,,,,,,,,Jann1997
17,Augustin 1996,39,1996,Haloperidol,18,,,,,,,,,,,,,,,,"Augustin BG, Jann MW, Crabtree BL, Pitts WM, Carter JG. Plasma alpha-one acid glycoprotein (aag) and haloperidol (h) concentrations in schizophrenic patients: 20th collegium internationale neuro- psychopharmacologicum congress; 1996 jun 23-27; melbourne, australia. 1996",,,kein Artikel auffindbar,,Augustin1996
17,Augustin 1996,40,1996,Placebo,18,,,,,,,,,,,,,,,,,,,,,Augustin1996
904,Study RIS-USA-72 1996,3029,1996,Risperidone,163,,,,,,,,,,,,,,,,"1996 SR-U-7. Office of clinical pharmacology and biopharmacy review. NDA number: 20272. Janssen-Cilag, data on file 1996",,,kein Artikel auffindbar,,JanssenCilag1996
904,Study RIS-USA-72 1996,3028,1996,Placebo,83,,,,,,,,,,,,,,,,,,,,,JanssenCilag1996
659,Fabre 1995,2445,1995,Quetiapine,8,,,,,,,,,,,,,,,,"Fabre Jr LF, Arvanitis L, Pultz J, Jones VM, Malick JB, Slotnick VB. ICI 2044,636, a novel, atypical antipsychotic: Early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. clinical Therapeutics 1995",,,keine Kontakte auffindbar,,Fabre1995
659,Fabre 1995,2444,1995,Placebo,4,,,,,,,,,,,,,,,,,,,,,Fabre1995
828,Pathiraja 1995a,2828,1995,Placebo,7,,,,,,,,,,,,,,,,"Pathiraja AP, Diamond BI, Borison RL, Meibech RC, Anand R. Relationship between creatine phosphokinase, psychotic symptoms and novel antipsychotic drugs conference abstract: Schizophrenia research (the vth international congress on schizophrenia research, wormsprings, va usa. 6th-12th april, 1995.). 1995",,,keine Kontakte auffindbar,,Pathiraja1995
828,Pathiraja 1995a,2829,1995,Risperidone,18,,,,,,,,,,,,,,,,,,,,,Pathiraja1995
828,Pathiraja 1995b,2828,1995,Placebo,7,,,,,,,,,,,,,,,,"Pathiraja AP, Diamond BI, Borison RL, Meibech RC, Anand R. Relationship between creatine phosphokinase, psychotic symptoms and novel antipsychotic drugs conference abstract: Schizophrenia research (the vth international congress on schizophrenia research, wormsprings, va usa. 6th-12th april, 1995.). 1995",,,keine Kontakte auffindbar,,Pathiraja1995
828,Pathiraja 1995b,2827,1995,Haloperidol,10,,,,,,,,,,,,,,,,,,,,,Pathiraja1995
2987,Faustman 1995,7732,1995,Quetiapine,5,,,,,,,,,,,,,,,,"Faustman WO, Ringo DL, Lauriello J et al. Effects if seroquel (ici 204 636) on platelet serotonin-2 binding in schizophrenia conference abstract: Schizophrenia research (the vth international congress on schizophrenia research, wormsprings, va usa. 6th-12th april, 1995.). 1995",Professor  Faustman,faust2@stanford.edu,,,Faustman1995
2987,Faustman 1995,8136,1995,Placebo,4,,,,,,,,,,,,,,,,,,,,,Faustman1995
298,Marder 1994a,629,1994,Risperidone,64,,,,,,19,11,45,endpoint,sd estimated from mean of SDs,,,,,,"Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. American Journal of Psychiatry 1994",Dr Marder,marder@ucla.edu,,,Marder1994
298,Marder 1994a,628,1994,Placebo,66,,,,,,11,17,51,endpoint,sd estimated from mean of SDs,,,,,,,,,,,Marder1994
298,Marder 1994b,627,1994,Haloperidol,66,,,,,,19,22,55,endpoint,sd estimated from mean of SDs,,,,,,,,,,,Marder1994
298,Marder 1994b,628,1994,Placebo,66,,,,,,11,17,51,endpoint,sd estimated from mean of SDs,,,,,,,,,,,Marder1994
3397,Potkin 1994,8948,1994,Clozapine,,,,,,,,,,,,,,,,,"Potkin SG, Buchsbaum MS, Jin Y et al. Clozapine effects of glucose metabolic rate in striatum and frontal cortex. Journal of clinical Psychiatry 1994",Professor Potkin,sgpotkin@uci.edu,,,Potkin1994
3397,Potkin 1994,9132,1994,Placebo,,,,,,,,,,,,,,,,,,,,,,Potkin1994
75,Chouinard 1993a,167,1993,Placebo,22,,,,,,,,,,,,,,,,"Chouinard G, Jones B, Remington G et al. A canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.[Erratum appears in j clin psychopharmacol 1993 apr;13(2): 149]. Journal of clinical Psychopharmacology 1993",,,keine Kontakte auffindbar,,Chouinard1993
75,Chouinard 1993a,168,1993,Risperidone,22,,,,,,,,,,,,,,,,,,,,,Chouinard1993
75,Chouinard 1993b,167,1993,Placebo,22,,,,,,,,,,,,,,,,"Chouinard G, Jones B, Remington G et al. A canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.[Erratum appears in j clin psychopharmacol 1993 apr;13(2): 149]. Journal of clinical Psychopharmacology 1993",,,keine Kontakte auffindbar,,Chouinard1993
75,Chouinard 1993b,166,1993,Haloperidol,21,,,,,,,,,,,,,,,,,,,,,Chouinard1993
768,Lemmer 1993,2688,1993,Haloperidol,,,,,,,,,,,,,,,,,"Lemmer W, Klieser E, Klimke A. Experimental comparison of the efficacy of the dopamine autoreceptor agonist pramipexole versus haloperidol and placebo in acute schizophrenics: Pharmacopsychiatry. 1993",Dr Klimke,ansgar.klimke@vitos-hochtaunus.de,,,Lemmer1993
768,Lemmer 1993,2689,1993,Placebo,,,,,,,,,,,,,,,,,,,,,,Lemmer1993
323,Montgomery 1992,682,1992,Placebo,33,,,,,,,,,,,,,,,,"Montgomery SA, Green M, Rimon R et al. Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia. Acta Psychiatrica Scandinavica 1992",Professor Montgomery,Stuart@samontgomery.co.uk,,"hat keine Daten, nochmals Rückfrage gestellt",
323,Montgomery 1992,683,1992,Thioridazine,32,,,,,,,,,,,,,,,,,,,,"hat keine Daten, nochmals Rückfrage gestellt",
559,Borison 1992a,2269,1992,Placebo,54,-1.2,5,54,change,sd estimated from mean of SDs,,,,,,410.8,27.8793918087135,44,endpoint,sd estimated from mean of SDs,"Borison RL, Pathiraja AP, Diamond BI, Meibach RC. Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacology Bulletin 1992",Dr Meibach,jessicasmith.asent@gmail.com,unsicherer Kontakt,,Borison1992
559,Borison 1992a,2270,1992,Risperidone,53,1.9,6.02,53,change,Problematic because pvalue only in treatment arm,,,,,,411.8,27.8793918087135,50,endpoint,sd estimated from mean of SDs,,,,,,Borison1992
559,Borison 1992b,2269,1992,Placebo,54,-1.2,5,54,change,sd estimated from mean of SDs,,,,,,410.8,27.8793918087135,44,endpoint,sd estimated from mean of SDs,"Borison RL, Pathiraja AP, Diamond BI, Meibach RC. Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacology Bulletin 1992",Dr Meibach,jessicasmith.asent@gmail.com,unsicherer Kontakt,,Borison1992
559,Borison 1992b,2168,1992,Haloperidol,53,0.8,5,53,change,sd estimated from mean of SDs,,,,,,408.5,27.8793918087135,47,endpoint,sd estimated from mean of SDs,,,,,,Borison1992
47,Borison 1991a,108,1991,Chlorpromazine,9,,,,,,,,,,,,,,,,,,,,,Borison1991
47,Borison 1991a,109,1991,Placebo,10,,,,,,,,,,,,,,,,,,,,,Borison1991
192,"Herrera 1990, 00640",389,1990,Placebo,5,,,,,,,,,,,,,,,,"Herrera J, Costa J, Sramek J et al. The efficacy of sustained-release thioridazine in the treatment of schizophrenic inpatients. Current Therapeutic Research - clinical and Experimental 1990",,,kein Artikel auffindbar,,Herrera1990
192,"Herrera 1990, 00640",390,1990,Thioridazine,9,,,,,,,,,,,,,,,,,,,,,Herrera1990
350,"Pi 1990, 01400",741,1990,Thioridazine,7,,,,,,,,,,,,,,,,"Pi E, Sramek J, Johnson T et al. Subjective neuroleptic response and treatment outcome under open and double- blind conditions - a preliminary report. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1990",Professor Pi,EHPI@USC.edu,,,Pi1990
350,"Pi 1990, 01400",740,1990,Placebo,5,,,,,,,,,,,,,,,,,,,,,Pi1990
584,Chouinard 1990,2308,1990,Chlorpromazine,21,,,,,,,,,,,,,,,,"Chouinard G. A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation. Acta Psychiatrica Scandinavica, Supplementum 1990",,,keine Kontakte auffindbar,,Chouinard1990
584,Chouinard 1990,2309,1990,Placebo,21,,,,,,,,,,,,,,,,,,,,,Chouinard1990
248,Klieser 1989,512,1989,Placebo,16,,,,,,,,,,,,,,,,"Klieser E, Lehmann E. Experimental examination of trazodone. clinical Neuropharmacology 1989",Professor Klieser,neurologie@evk-ge.de,geht an Sekretariat Memory Clinic,,Klieser1989
248,Klieser 1989,511,1989,Haloperidol,22,,,,,,,,,,,,,,,,,,,,,Klieser1989
557,Borison 1989a,2164,1989,Thioridazine,8,,,,,,,,,,,,,,,,"Borison RL, Sinha D, Haverstock S, McLarnon MC, Diamond BI. Efficacy and safety of tiospirone vs. Haloperidol and thioridazine in a double-blind, placebo-controlled trial. Psychopharmacology Bulletin 1989",,,Gefängnis,,Borison1989
557,Borison 1989a,2163,1989,Placebo,8,,,,,,,,,,,,,,,,,,,,,Borison1989
557,Borison 1989b,2162,1989,Haloperidol,8,,,,,,,,,,,,,,,,,,,,,Borison1989
557,Borison 1989b,2163,1989,Placebo,8,,,,,,,,,,,,,,,,,,,,,Borison1989
702,Honigfeld 1984a,2549,1984,Placebo,8,,,,,,,,,,,,,,,,"Honigfeld G, Patin J, Singer J. Clozapine: Antipsychotic activity in treatment-resistant schizophrenics. Advances in Therapy 1984",,,keine Kontakte auffindbar,,Honigfeld1984
702,Honigfeld 1984a,2547,1984,Clozapine,16,,,,,,,,,,,,,,,,,,,,,Honigfeld1984
702,Honigfeld 1984b,2549,1984,Placebo,8,,,,,,,,,,,,,,,,"Honigfeld G, Patin J, Singer J. Clozapine: Antipsychotic activity in treatment-resistant schizophrenics. Advances in Therapy 1984",,,keine Kontakte auffindbar,,Honigfeld1984
702,Honigfeld 1984b,2548,1984,Chlorpromazine,15,,,,,,,,,,,,,,,,,,,,,Honigfeld1984
547,Bechelli 1983,2260,1983,Haloperidol,30,,,,,,,,,,,,,,,,"Bechelli LP, Ruffino-Netto A, Hetem G. A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients. Brazilian Journal of Medical & Biological Research 1983",Dr Bechelli,bechelli@netsite.com.br,"Kontakt falsch, kein neuer auffindbar",,Bechelli1983
547,Bechelli 1983,2261,1983,Placebo,31,,,,,,,,,,,,,,,,,,,,,Bechelli1983
224,"Johnstone 1978, 01073",458,1978,Flupentixol,15,,,,,,,,,,,,,,,,"Johnstone EC, Crow TJ, Frith CD, Carney MW, Price JS. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1978",Professor Johnstone,alumni@ed.ac.uk,unsicherer Kontakt,melden sich noch,Johnstone1978
224,"Johnstone 1978, 01073",459,1978,Placebo,15,,,,,,,,,,,,,,,,,,,,,Johnstone1978
798,McInnes 1978,2746,1978,Placebo,9,,,,,,,,,,,,,,,,"McInnes EJ, Walker F, Snelling E. The observer interaction variable in evaluation of socialising properties of pimozide (orap). New Zealand Medical Journal 1978",,,keine Kontakte auffindbar,,McInnes1978
798,McInnes 1978,2765,1978,Pimozide,9,,,,,,,,,,,,,,,,,,,,,McInnes1978
105,"Clark 1977 12 weeks, 02912",199,1977,Placebo,13,,,,,,,,,,,,,,,,"Clark ML, Paredes A, Costiloe JP, Wood F. Evaluation of butaclamol in chronic schizophrenic patients. Journal of clinical Pharmacology 1977",,,keine Kontakte auffindbar,,"Clark1977b,"
105,"Clark 1977 12 weeks, 02912",76205,1977,Loxapine,25,,,,,,,,,,,,,,,,,,,,,"Clark1977b,"
106,Clark 1977a,201,1977,Chlorpromazine,9,,,,,,,,,,,,,,,,,,,,,Clark1977a
106,Clark 1977a,202,1977,Placebo,9,,,,,,,,,,,,,,,,,,,,,Clark1977a
386,Sakalis 1977,818,1977,Chlorpromazine,33,,,,,,,,,,,,,,,,"Sakalis G, Chan TL, Sathananthan G, Schooler N, Goldberg S, Gershon S. Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios. Communications in Psychopharmacology 1977",,,keine Kontakte auffindbar,,Sakalis1977
386,Sakalis 1977,819,1977,Placebo,17,,,,,,,,,,,,,,,,,,,,,Sakalis1977
401,Spohn 1977,897,1977,Placebo,20,,,,,,,,,,,,,,,,"Spohn HE, Lacoursiere RB, Thompson K, Coyne L. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. Archives of General Psychiatry 1977",,,beide Autoren verstorben,,Spohn1977
401,Spohn 1977,896,1977,Chlorpromazine,20,,,,,,,,,,,,,,,,,,,,,Spohn1977
295,Mahal 1976,620,1976,Chlorpromazine,27,,,,,,,,,,,,,,,,"Mahal AS, Ramu NG, Chaturvedi DD. Double blind controlled study of brahmyadiyoga and tagara in the management of various types of unmada (schizophrenia). Indian Journal of Psychiatry 1976",,,keine Kontakte auffindbar,,Mahal1976
295,Mahal 1976,621,1976,Placebo,27,,,,,,,,,,,,,,,,,,,,,Mahal1976
597,Selman 1976a,2952,1976,Haloperidol,29,,,,,,,,,,,,,,,,"Selman FB, McClure RF, Helwig H. Loxapine succinate: A double-blind comparison with haloperidol and placebo in acute schizophrenics. Current Therapeutic Research, clinical & Experimental 1976",,,Letztautor verstorben,,Selman1976
597,Selman 1976a,2954,1976,Placebo,29,,,,,,,,,,,,,,,,,,,,,Selman1976
597,Selman 1976b,2953,1976,Loxapine,29,,,,,,,,,,,,,,,,,,,,,Selman1976
597,Selman 1976b,2954,1976,Placebo,29,,,,,,,,,,,,,,,,,,,,,Selman1976
24,Ban 1975e,54,1975,Chlorpromazine,10,,,,,,,,,,,,,,,,"Ban TA, Lehmann HE, Sterlin C, Climan M. Comprehesiven clinical studies with thiothixene. Diseases of the Nervous System 1975",Dr Ban,inhn@inhn.org,unischerer Kontakt,,Ban1975
24,Ban 1975e,55,1975,Placebo,10,,,,,,,,,,,,,,,,,,,,,Ban1975
24,Ban 1975d,56,1975,Thiothixene,10,,,,,,,,,,,,,,,,,,,,,Ban1975
24,Ban 1975d,55,1975,Placebo,10,,,,,,,,,,,,,,,,,,,,,Ban1975
104,Clark 1975a,195,1975,Placebo,13,,,,,,,,,,,,,,,,"Clark ML, Paredes A, Costiloe JP, Wood F, Barrett A. Loxapine in newly admitted chronic schizophrenic patients. Journal of clinical Pharmacology 1975",,,keine Kontakte auffindbar,,Clark1975
104,Clark 1975a,196,1975,Trifluoperazine,15,,,,,,,,,,,,,,,,,,,,,Clark1975
104,Clark 1975b,195,1975,Placebo,13,,,,,,,,,,,,,,,,"Clark ML, Paredes A, Costiloe JP, Wood F, Barrett A. Loxapine in newly admitted chronic schizophrenic patients. Journal of clinical Pharmacology 1975",,,keine Kontakte auffindbar,,Clark1975
104,Clark 1975b,194,1975,Loxapine,15,,,,,,,,,,,,,,,,,,,,,Clark1975
583,Chouinard 1975,2306,1975,Placebo,24,,,,,,,,,,,,,,,,"Chouinard G, Annable L, Serrano M, Albert JM, Charette R. Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction. Archives of General Psychiatry 1975",,,keine Kontakte auffindbar,,Chouinard1975
583,Chouinard 1975,2307,1975,Perphenazine,24,,,,,,,,,,,,,,,,,,,,,Chouinard1975
922,van der Velde 1975a,3067,1975,Placebo,28,,,,,,,,,,,,,,,,"van der Velde, C. D., Kiltie H. Effectiveness of loxapine succinate in acute schizophrenia: A comparative study with thiothixene. Current Therapeutic Research, clinical & Experimental 1975",,,Erstautor verstorben,,VanDerVelde1975
922,van der Velde 1975a,3068,1975,Thiothixene,28,,,,,,,,,,,,,,,,,,,,,VanDerVelde1975
922,van der Velde 1975b,3067,1975,Placebo,28,,,,,,,,,,,,,,,,"van der Velde, C. D., Kiltie H. Effectiveness of loxapine succinate in acute schizophrenia: A comparative study with thiothixene. Current Therapeutic Research, clinical & Experimental 1975",,,Erstautor verstorben,,VanDerVelde1975
922,van der Velde 1975b,3066,1975,Loxapine,26,,,,,,,,,,,,,,,,,,,,,VanDerVelde1975
71,"Charalampous 1974, 00559a",159,1974,Thiothixene,21,,,,,,,,,,,,,,,,"Charalampous KD, Freemesser GF, Malev J, Ford K. Loxapine succinate: A controlled double-blind study in schizophrenia. Current Therapeutic Research, clinical & Experimental 1974",Professor Charalampous,kdxmd@hal-pc.org,,meldet sich noch,Charalampous1974
71,"Charalampous 1974, 00559a",158,1974,Placebo,19,,,,,,,,,,,,,,,,,,,,,Charalampous1974
71,"Charalampous 1974, 00559b",157,1974,Loxapine,20,,,,,,,,,,,,,,,,,,,,,Charalampous1974
71,"Charalampous 1974, 00559b",158,1974,Placebo,19,,,,,,,,,,,,,,,,,,,,,Charalampous1974
823,"Nistico 1974,",2817,1974,Placebo,20,,,,,,,,,,,,,,,,"Nistico G, Ragozzine D, Marano V. A comparative study of penfluridol and flupentixol in the treatment of chronic schizophrenia. Journal of clinical Pharmacology 1974",Professor Nistico,nistico@ebri.it,,,Nistico1974
823,"Nistico 1974,",2818,1974,Penfluridol,20,,,,,,,,,,,,,,,,,,,,,Nistico1974
226,Judd 1973,463,1973,Thioridazine,12,,,,,,,,,,,,,,,,"Judd LL, Goldstein MJ, Rodnick EH. Phenothiazine effects in good premorbid schizophrenics divided into paranoid nonparanoid status. Archives of General Psychiatry 1973",,,Erstautor verstorben,,Judd1973
226,Judd 1973,462,1973,Placebo,12,,,,,,,,,,,,,,,,,,,,,Judd1973
246,Klein 1973,508,1973,Placebo,42,,,,,,,,,,,,,,,,"Klein DF, Rosen B. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients. Archives of General Psychiatry 1973",,,Erstautor verstorben,,Klein1973
246,Klein 1973,507,1973,Chlorpromazine,46,,,,,,,,,,,,,,,,,,,,,Klein1973
88,Serafetinides 1972a,852,1972,Chlorpromazine,14,,,,,,,,,,,,,,,,"Serafetinides EA, Willis D, Clark ML. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Journal of Nervous & Mental Disease 1972",,,keine Kontakte auffindbar,,Serafetinides1972
88,Serafetinides 1972a,854,1972,Placebo,14,,,,,,,,,,,,,,,,,,,,,Serafetinides1972
88,Serafetinides 1972b,851,1972,Clopenthixol,15,,,,,,,,,,,,,,,,,,,,,Serafetinides1972
88,Serafetinides 1972b,854,1972,Placebo,14,,,,,,,,,,,,,,,,,,,,,Serafetinides1972
88,Serafetinides 1972c,853,1972,Haloperidol,14,,,,,,,,,,,,,,,,,,,,,Serafetinides1972
88,Serafetinides 1972c,854,1972,Placebo,14,,,,,,,,,,,,,,,,,,,,,Serafetinides1972
174,Goldberg 1972,348,1972,Chlorpromazine,,,,,,,,,,,,,,,,,"Goldberg SC, Frosch WA, Drossman AK, Schooler NR, Johnson GF. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study. Archives of General Psychiatry 1972",,,Erstautor verstorben,,Goldberg1972
174,Goldberg 1972,349,1972,Placebo,,,,,,,,,,,,,,,,,,,,,,Goldberg1972
315,Menon 1972,665,1972,Placebo,20,,,,,,,,,,,,,,,,"Menon MS, Ramachandran V. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients. Current Therapeutic Research, clinical & Experimental 1972",Dr Menon,surajmenonm@gmail.com,,,Menon1972
315,Menon 1972,666,1972,Trifluoperazine,20,,,,,,,,,,,,,,,,,,,,,Menon1972
658,Evans 1972,2442,1972,Placebo,27,,,,,,,,,,,,,,,,"Evans JR, Rodnick EH, Goldstein MJ, Judd LL. Premorbid adjustment, phenothiazine treatment, and remission in acute schizophrenics. Archives of General Psychiatry 1972",,,beide Autoren verstorben,,Evans1972
658,Evans 1972,2443,1972,Thioridazine,27,,,,,,,,,,,,,,,,,,,,,Evans1972
2291,Mezquita 1972,6573,1972,Placebo,43,,,,,,,,,,,,,,,,"Mezquita Blanco J, Cubillo Sanchez J, Aizpiri Diaz J, Zubia Zubia B. [clinical trial with sulpiride and placebo in chronic schizophrenics (study of 89 patients using the harris-letemendia-willems scale)]. Archivos de Neurobiologia 1972",,,keine Kontakte auffindbar,,Mezquita1972
2291,Mezquita 1972,6574,1972,Sulpiride,46,,,,,,,,,,,,,,,,,,,,,Mezquita1972
83,Clark 1971a,190,1971,Thioridazine,22,,,,,,,,,,,,,,,,"Clark ML, Huber WK, Charalampous KD, Serafetinides EA, Trousdale W, Colmore JP. Drug treatment in newly admitted schizophrenic patients. Archives of General Psychiatry 1971",,,keine Kontakte auffindbar,,Clark1971
83,Clark 1971a,189,1971,Placebo,21,,,,,,,,,,,,,,,,,,,,,Clark1971
83,Clark 1971b,188,1971,Fluphenazine,20,,,,,,,,,,,,,,,,,,,,,Clark1971
83,Clark 1971b,189,1971,Placebo,21,,,,,,,,,,,,,,,,,,,,,Clark1971
83,Clark 1971c,187,1971,Chlorpromazine,23,,,,,,,,,,,,,,,,,,,,,Clark1971
83,Clark 1971c,189,1971,Placebo,21,,,,,,,,,,,,,,,,,,,,,Clark1971
928,Vichaya 1971,3079,1971,Haloperidol,15,,,,,,,,,,,,,,,,Vichaiya V. clinical trial of haloperidol in schizophrenia. Journal of Psychiatric Association of Thailand 1971,,,keine Kontakte auffindbar,,Vichaiya1971
928,Vichaya 1971,3080,1971,Placebo,15,,,,,,,,,,,,,,,,,,,,,Vichaiya1971
591,Clark 1970b,2327,1970,Molindone,15,,,,,,,,,,,,,,,,,,,,,Clark1970
80,Clark 1969a,181,1969,Placebo,16,,,,,,,,,,,,,,,,Clark. Haloperidol versus chlorpromazine versus placebo: Psychopharmacology bulletin. 1969,,,keine Kontakte auffindbar,,"Clark1969,"
80,Clark 1969a,180,1969,Haloperidol,14,,,,,,,,,,,,,,,,,,,,,"Clark1969,"
80,Clark 1969b,181,1969,Placebo,16,,,,,,,,,,,,,,,,Clark. Haloperidol versus chlorpromazine versus placebo: Psychopharmacology bulletin. 1969,,,keine Kontakte auffindbar,,"Clark1969,"
80,Clark 1969b,179,1969,Chlorpromazine,14,,,,,,,,,,,,,,,,,,,,,"Clark1969,"
429,Tetreault 1969a,964,1969,Chlorpromazine,15,,,,,,,,,,,,,,,,"Tetreault L, Bordeleau JM, Gauthier R, Vulpe M, Lapointe L. Comparative study of tps-23, chlorpromazine and placebo in chronic schizophrenic patients. Diseases of the Nervous System 1969",,,"keine Kontakte auffindbar, Letztautor verstorben",,Tetreault1969
429,Tetreault 1969a,965,1969,Placebo,15,,,,,,,,,,,,,,,,,,,,,Tetreault1969
655,"Engelhardt 1969, 03748",2435,1969,Chlorpromazine,103,,,,,,,,,,,,,,,,"Engelhardt DM, Margolis RA, Rudorfer L, Paley HM. Physician bias and the double-blind. Archives of General Psychiatry 1969",,,Erstautor verstorben,,Engelhardt1969
655,"Engelhardt 1969, 03748",2436,1969,Placebo,99,,,,,,,,,,,,,,,,,,,,,Engelhardt1969
3294,Kordas 1968a,8845,1968,Chlorpromazine,18,,,,,,,,,,,,,,,,"Kordas SK, Kazamias NG, Georgas JG, Papadokostakis JG. Clopenthixol: A controlled trial in chronic hospitalized schizophrenic patients. British Journal of Psychiatry 1968",,,keine Kontakte auffindbar,,Kordas1968
3294,Kordas 1968a,9092,1968,Placebo,18,,,,,,,,,,,,,,,,,,,,,Kordas1968
3294,Kordas 1968b,8989,1968,Clopenthixol,18,,,,,,,,,,,,,,,,,,,,,Kordas1968
3294,Kordas 1968b,9092,1968,Placebo,18,,,,,,,,,,,,,,,,,,,,,Kordas1968
77,Clark 1967,171,1967,Chlorpromazine,51,,,,,,,,,,,,,,,,"Clark ML, Ray TS, Paredes A et al. Chlorpromazine in women with chronic schizophrenia: The effect on cholesterol levels and cholesterol-behavior relationships. Psychosomatic Medicine 1967",,,keine Kontakte auffindbar,,Clark1967
77,Clark 1967,172,1967,Placebo,21,,,,,,,,,,,,,,,,,,,,,Clark1967
390,Saretsky 1966,826,1966,Chlorpromazine,20,,,,,,,,,,,,,,,,Saretsky T. Effects of chlorpromazine on primary-process thought manifestations. Journal of Abnormal Psychology 1966,,,keine Kontakte auffindbar,,Saretsky1966
390,Saretsky 1966,827,1966,Placebo,20,,,,,,,,,,,,,,,,,,,,,Saretsky1966
857,Reardon 1966a,2891,1966,Chlorpromazine,11,,,,,,,,,,,,,,,,"Reardon JD, Abrams S. Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo). Diseases of the Nervous System 1966",,,keine Kontakte auffindbar,,Reardon1966
857,Reardon 1966a,2892,1966,Placebo,12,,,,,,,,,,,,,,,,,,,,,Reardon1966
857,Reardon 1966b,2893,1966,Trifluoperazine,11,,,,,,,,,,,,,,,,,,,,,Reardon1966
857,Reardon 1966b,2892,1966,Placebo,12,,,,,,,,,,,,,,,,,,,,,Reardon1966
42,Bishop 1964,95,1964,Placebo,14,,,,,,,,,,,,,,,,Bishop MPGDM. Behavioral toxicity associated with benzquinamide (quantril) therapy in schizophrenic patients: American journal of psychiatry. 1963,Professor Gallant,dgallant@uthsc.edu,,,Bishop1964
42,Bishop 1964,96,1964,Trifluoperazine,14,,,,,,,,,,,,,,,,,,,,,Bishop1964
41,Bishop 1963c,92,1963,Chlorpromazine,10,,,,,,,,,,,,,,,,,,,,,Bishop1963
41,Bishop 1963c,93,1963,Placebo,10,,,,,,,,,,,,,,,,,,,,,Bishop1963
668,Gallant 1963,2462,1963,Chlorpromazine,,,,,,,,,,,,,,,,,"Gallant DM, Bishop MP. Molindone: A controlled evaluation in chronic schizophrenic patients. Current Therapeutic Research, clinical & Experimental 1968",Professor Gallant,dgallant@uthsc.edu,,,Gallant1963
668,Gallant 1963,2463,1963,Placebo,,,,,,,,,,,,,,,,,,,,,,Gallant1963
672,Garry 1962b,2472,1962,Placebo,26,,,,,,,,,,,,,,,,"Garry JW, Leonard TJ. Haloperidol: A controlled trial in chronic schizophrenia. J Ment Sci 1962",,,keine Kontakte auffindbar,,Garry1962
672,Garry 1962b,2471,1962,Haloperidol,26,,,,,,,,,,,,,,,,,,,,,Garry1962
261,Kurland 1961a,540,1961,Placebo,37,,,,,,,,,,,,,,,,"Kurland AA, Hanlon TE, Tatom MH, Ota KY, Simopoulos AM. The comparative effectiveness of six phenothiazine compounds, phenobarbital and intert placebo in the treatment of acutely ill patients: Global measures of severity of illness: Journal of nervous and mental disease. 1961",,,Erstautor verstorben,,Kurland1961
261,Kurland 1961a,538,1961,Chlorpromazine,33,,,,,,,,,,,,,,,,,,,,,Kurland1961
261,Kurland 1961b,540,1961,Placebo,37,,,,,,,,,,,,,,,,"Kurland AA, Hanlon TE, Tatom MH, Ota KY, Simopoulos AM. The comparative effectiveness of six phenothiazine compounds, phenobarbital and intert placebo in the treatment of acutely ill patients: Global measures of severity of illness: Journal of nervous and mental disease. 1961",,,Erstautor verstorben,,Kurland1961
261,Kurland 1961b,541,1961,Perphenazine,36,,,,,,,,,,,,,,,,,,,,,Kurland1961
770,Levita 1961,2693,1961,Placebo,9,,,,,,,,,,,,,,,,Levita E. Effects of chlorpromazine and promazine on perseveration. Journal of General Psychology 1961,,,keine Kontakte auffindbar,,Levita1961
770,Levita 1961,2692,1961,Chlorpromazine,13,,,,,,,,,,,,,,,,,,,,,Levita1961
2280,Howell 1961a,6549,1961,Fluphenazine,,,,,,,,,,,,,,,,,,,,,,Howell1961
2280,Howell 1961a,6550,1961,Placebo,,,,,,,,,,,,,,,,,"Howell RJ, Brown, H. M., Jr., Beaghler HE. A comparison of fluphenazine, trifluoperazine and a placebo in the context of an active treatment unit. J Nerv Ment Dis 1961",,,keine Kontakte auffindbar,,Howell1961
2280,Howell 1961b,6551,1961,Trifluoperazine,,,,,,,,,,,,,,,,,,,,,,Howell1961
2280,Howell 1961b,6550,1961,Placebo,,,,,,,,,,,,,,,,,"Howell RJ, Brown, H. M., Jr., Beaghler HE. A comparison of fluphenazine, trifluoperazine and a placebo in the context of an active treatment unit. J Nerv Ment Dis 1961",,,keine Kontakte auffindbar,,Howell1961
575,Casey 1960,2211,1960,Placebo,178,,,,,,,,,,,,,,,,"Casey JF, Bennett IF, Lindley CJ, Hollister LE, Gordon MH, Springer NN. Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo. AMA Arch Gen Psychiatry 1960",,,keine Kontakte auffindbar,,Casey1960
575,Casey 1960,2210,1960,Chlorpromazine,170,,,,,,,,,,,,,,,,,,,,,Casey1960
830,Payne 1960,2832,1960,Chlorpromazine,7,,,,,,,,,,,,,,,,"Payne P. A comparison of trifluopromazine, chlorpromazine, and a placebo in twenty-one chronic schizophrenic patients. 1960",,,keine Kontakte auffindbar,,Payne1960
830,Payne 1960,2833,1960,Placebo,7,,,,,,,,,,,,,,,,,,,,,Payne1960
872,Sandison 1960,2761,1960,Thioridazine,8,,,,,,,,,,,,,,,,Sandison RAWECJDC. clinical trials with melleril (tp21) in the treatment of schizophrenia. A two-year study: Journal of mental science. 1960,,,Erstautor versotrben; keine Kontakte auffindbar,,Sandison1960
872,Sandison 1960,2760,1960,Placebo,7,,,,,,,,,,,,,,,,,,,,,Sandison1960
536,Baker 1959,2236,1959,Chlorpromazine,7,,,,,,,,,,,,,,,,Baker JP. A controlled trial of ethylcrotonylurea. JMentSci 1959,,,keine Kontakte auffindbar,,Baker1959
536,Baker 1959,2237,1959,Placebo,8,,,,,,,,,,,,,,,,,,,,,Baker1959
666,Fleming 1959,2458,1959,Chlorpromazine,12,,,,,,,,,,,,,,,,"Fleming BG, Spencer AM, Whitelaw EM. A controlled comparative investigation of the effects of promazine, chlorpromazine, and a placebo in chronic psychosis. J Ment Sci 1959",,,keine Kontakte auffindbar,,Fleming1959
666,Fleming 1959,2459,1959,Placebo,12,,,,,,,,,,,,,,,,,,,,,Fleming1959
742,King 1959,2635,1959,Placebo,24,,,,,,,,,,,,,,,,King PDWW. Comparison of proclorperazine and chlorpromazine in hospitalized chronic schizophrenics: American journal of psychiatry. 1959,,,beide Autoren verstorben,,King1959
742,King 1959,2634,1959,Chlorpromazine,24,,,,,,,,,,,,,,,,,,,,,King1959
933,Walsh 1959,3092,1959,Placebo,22,,,,,,,,,,,,,,,,"Walsh GP, Walton D, Black DA. The relative efficacy of Vespral and chlorpromazine in the treatment of a group of chronic schizophrenic patients. British Journal of Psychiatry 1959",,,keine Kontakte auffindbar,,Walsh1959
933,Walsh 1959,3091,1959,Chlorpromazine,22,,,,,,,,,,,,,,,,,,,,,Walsh1959
2276,Haug 1959,6541,1959,Placebo,,,,,,,,,,,,,,,,,Haug JO. [A controlled clinical trial of thioridazine (melleril); a new phenothiazine derivative]. Tidsskrift for Den Norske Laegeforening 1959,,,keine Kontakte auffindbar,,Haug1959
2276,Haug 1959,6542,1959,Thioridazine,,,,,,,,,,,,,,,,,,,,,,Haug1959
281,Little 1958,592,1958,Chlorpromazine,,,,,,,,,,,,,,,,,"Little JC. A double-blind controlled comparison of the effects of chlorpromazine, barbiturate and a placebo in 142 chronic psychotic in-patients. Journal of Mental Science 1958",,,keine Kontakte auffindbar,,Little1958
281,Little 1958,593,1958,Placebo,,,,,,,,,,,,,,,,,,,,,,Little1958
3488,Fleming 1958,9236,1958,Chlorpromazine,,,,,,,,,,,,,,,,,"Fleming B, Currie J. Investigation of a new compound, b.w.203, and of chlorpromazine in the treatment of psychosis: Journal-of-mental-science-(br-j-psychiatry-from-1963). 1968",,,keine Kontakte auffindbar,,Fleming1958
3488,Fleming 1968,9266,1958,Placebo,,,,,,,,,,,,,,,,,,,,,,Fleming1958
602,"Sheperd 1956, 01660",2967,1956,Placebo,8,,,,,,,,,,,,,,,,"Shepherd M, Watt DC. A controlled clinical study of chlorpromazine and reserpine in chronic schizophrenia: Journal of neurochemistry. 1956",,,keine Kontakte auffindbar,,Shepherd1956
602,"Sheperd 1956, 01660",2966,1956,Chlorpromazine,8,,,,,,,,,,,,,,,,,,,,,Shepherd1956
688,Hall 1955,2496,1955,Chlorpromazine,87,,,,,,,,,,,,,,,,Hall RADDJ. A study of chlorpromazine: Methodology and results with chronic semi-disturbed schizophrenics: Journal of nervous and mental disease. 1955,,,beide Autoren verstorben,,Hall1955
688,Hall 1955,2515,1955,Placebo,88,,,,,,,,,,,,,,,,,,,,,Hall1955
